Publication:
Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

Simple item page
dc.contributor.authorsKilickap, S.; Ozturk, A.; Karadurmus, N.; Korkmaz, T.; Yumuk, P.; Cicin, I.; Paydas, S.; Cilbir, E.; Sakalar, T.; Uysal, M.; Uskent, N.; Demir, N.; Sakin, A.; Turhal, N.; Keskin, S.; Tural, D.; Eralp, Y.; Basal, F.; Yasar, H.; Sendur, M. A.; Demirci, U.; Cubukcu, E.; Karaagac, M.; Karaca, S.; Tatli, A.; Yetisyigit, T.; Urvay, S.; Gursoy, P.; Uluc, B. Oyan; Turna, Z.; Kucukoner, M.; Olmez, O.; Cabuk, D.; Seker, M.; Unal, O.; Meydan, N.; Okutur, S.; Tunali, D.
dc.date.accessioned2022-03-10T17:58:13Z
dc.date.accessioned2026-01-11T17:45:14Z
dc.date.available2022-03-10T17:58:13Z
dc.date.issued2018
dc.identifier.doidoiWOS:000454014501235
dc.identifier.eissn1556-1380
dc.identifier.issn1556-0864
dc.identifier.urihttps://hdl.handle.net/11424/222141
dc.identifier.wosWOS:000454014501235
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INC
dc.relation.ispartofJOURNAL OF THORACIC ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNSCLC
dc.subjectALK inhibitor
dc.subjectcrizotinib
dc.titleCrizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPageS478
oaire.citation.issue10
oaire.citation.startPageS477
oaire.citation.titleJOURNAL OF THORACIC ONCOLOGY
oaire.citation.volume13

Files

Collections

Araştırma Çıktıları